Polynovo Ltd Market Cap ($452.15 Million)

$452.15 Million USD  · AU$639.03 Million AUD  · Rank #12427

Market Cap & Net Worth: Polynovo Ltd (PNV)

Polynovo Ltd market cap. Polynovo Ltd (AU:PNV) has a market capitalization of $452.15 Million (AU$639.03 Million) as of November 5, 2026. Listed on the AU stock exchange, this Australia-based company holds position #12427 globally and #320 in its home market, demonstrating a 9.47% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Polynovo Ltd's stock price AU$0.93 by its total outstanding shares 690842991 (690.84 Million). Also see Polynovo Ltd cash flow conversion for how efficiently the company converts equity into cash flow.

Polynovo Ltd Market Cap History (2015–2026)

Polynovo Ltd market cap history from 2015 to 2026. Data shows growth from $141.76 Million to $452.15 Million (19.03% CAGR). Check PNV live share price for real-time trading data and today's change.

Index Memberships

Polynovo Ltd is a constituent of 4 market indices:

Index Total Market Cap Weight (%) Rank by Market Cap
Australia All Ordinaries
AORD
$2.01 Trillion 0.02% #229 of 495
S&P/ASX All Australian 200
AXAT
$1.92 Trillion 0.02% #176 of 200
S&P/ASX 300
AXKO
$2.16 Trillion 0.02% #222 of 300
ASX Small Ordinaries
AXSO
$284.93 Billion 0.16% #131 of 200

Weight: Polynovo Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Polynovo Ltd Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Polynovo Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore Polynovo Ltd (PNV) net asset momentum to track how rapidly the company is growing its equity base year over year.

Latest Price to Sales (P/S) Ratio

4.73x

Polynovo Ltd's market cap is 4.73 times its annual revenue

Industry average: 1.49x Higher than industry average

Latest Price to Earnings (P/E) Ratio

45.50x

Polynovo Ltd's market cap is 45.50 times its annual earnings

Industry average: 18.23x Higher than industry average

What These Ratios Tell Investors:

  • Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
  • Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
  • Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
  • Industry comparison provides context for whether the company is valued higher or lower than peers.
Year Market Cap (USD) Revenue (USD) Net Income (USD) P/S Ratio P/E Ratio
2016 $141.76 Million $3.28 Million -$3.06 Million 43.26x N/A
2017 $254.18 Million $3.62 Million -$5.01 Million 70.22x N/A
2018 $290.85 Million $6.55 Million -$5.97 Million 44.38x N/A
2019 $962.97 Million $14.04 Million -$3.19 Million 68.57x N/A
2020 $1.90 Billion $22.16 Million -$4.19 Million 85.60x N/A
2021 $745.44 Million $29.16 Million -$4.61 Million 25.57x N/A
2022 $987.41 Million $41.44 Million -$1.19 Million 23.83x N/A
2023 $808.99 Million $65.24 Million -$4.92 Million 12.40x N/A
2024 $997.18 Million $103.19 Million $5.26 Million 9.66x 189.54x
2025 $601.24 Million $127.24 Million $13.21 Million 4.73x 45.50x

Competitor Companies of PNV by Market Capitalization

Companies near Polynovo Ltd in the global market cap rankings as of November 5, 2026. Also see Polynovo Ltd total assets for a full breakdown of the balance sheet.

Key companies related to Polynovo Ltd by market ranking:

  • Abbott Laboratories (NYSE:ABT): Ranked #110 globally with a market cap of $190.23 Billion USD.
  • Stryker Corporation (NYSE:SYK): Ranked #204 globally with a market cap of $119.12 Billion USD.
  • Medtronic PLC (NYSE:MDT): Ranked #226 globally with a market cap of $109.30 Billion USD.
  • Medtronic plc (SA:MDTC34): Ranked #239 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
Market capitalization comparison (in billions USD)
Rank Company Symbol Market Cap Price
#110 Abbott Laboratories NYSE:ABT $190.23 Billion $109.40
#204 Stryker Corporation NYSE:SYK $119.12 Billion $310.55
#226 Medtronic PLC NYSE:MDT $109.30 Billion $98.88
#239 Medtronic plc SA:MDTC34 $104.84 Billion R$208.39

Market Capitalization of Polynovo Ltd (2015–2026)

Market capitalization of Polynovo Ltd from 2015 to today. Between 2015 and today, Polynovo Ltd's market cap moved from $141.76 Million to $ 452.15 Million, with a yearly change of 19.03%.

Year Market Cap Change (%)
2026 AU$452.15 Million -24.80%
2025 AU$601.24 Million -39.71%
2024 AU$997.18 Million +23.26%
2023 AU$808.99 Million -18.07%
2022 AU$987.41 Million +32.46%
2021 AU$745.44 Million -60.70%
2020 AU$1.90 Billion +96.95%
2019 AU$962.97 Million +231.09%
2018 AU$290.85 Million +14.42%
2017 AU$254.18 Million +79.31%
2016 AU$141.76 Million 0.00%
2015 AU$141.76 Million --

End of Day Market Cap According to Different Sources

On Nov 4th, 2026 the market cap of Polynovo Ltd was reported to be:

Source Market Cap
Yahoo Finance $452.15 Million USD
MoneyControl $452.15 Million USD
MarketWatch $452.15 Million USD
marketcap.company $452.15 Million USD
Reuters $452.15 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Polynovo Ltd

AU:PNV Australia Medical Devices
Market Cap
$452.15 Million
AU$639.03 Million AUD
Market Cap Rank
#12427 Global
#320 in Australia
Share Price
AU$0.93
Change (1 day)
+2.21%
52-Week Range
AU$0.82 - AU$1.29
All Time High
AU$4.01
About

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more